Holen Sie sich die Stockscreener-App
0.108
1.82%
-0.002
Finanzdaten der Cns Pharmaceuticals Inc-Aktie (CNSP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
34.10%
3.5449
|
5.3794 | 4.5338 | 4.0254 | 4.9265 |
| Interest Income/Expense |
129.95%
0.00663
|
0.00288 | 0.00184 | 0.00365 | 0.00544 |
| Operating Income/Loss |
34.10%
-3.5449
|
-5.3794 | -4.5338 | -4.0254 | -4.9265 |
| Nonoperating Income/Loss |
97.43%
0.000106
|
0.00412 | 0.011 | 0.00415 | -0.00544 |
| Income/Loss From Continuing Operations Before Tax |
34.05%
-3.5447
|
-5.3753 | -4.5228 | -4.0212 | -4.9319 |
| Income/Loss From Continuing Operations After Tax |
34.05%
-3.5447
|
-5.3753 | -4.5228 | -4.0212 | -4.9319 |
|
Net Income/Loss
|
34.05%
-3.5447
|
-5.3753 | -4.5228 | -4.0212 | -4.9319 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,881%
8.7127
|
0.4397 | 4.1771 | 3.8773 | 1.9065 |
| Diluted Average Shares |
1,881%
8.7127
|
0.4397 | 4.1771 | 3.8773 | 1.9065 |
| Basic Earnings Per Share |
56.84%
-0.41
|
-0.95 | -1.08 | -1.04 | -2.59 |
| Diluted Earnings Per Share |
56.84%
-0.41
|
-0.95 | -1.08 | -1.04 | -2.59 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):